Task: Answer the multiple choice question.
Query: Which drug exhibits a -58.528% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1sc2nc(CSc3ccccc3)nc(N3CCN(C)CC3)c2c1C
b.) CC1CC(N(C(=O)c2ccc(Cl)cc2)c2ccccc2)c2ccccc2N1C(=O)c1ccco1
Answer: a. Cc1sc2nc(CSc3ccccc3)nc(N3CCN(C)CC3)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2nc(CSc3ccccc3)nc(N3CCN(C)CC3)c2c1C
Cc1sc2nc(CSc3ccccc3)nc(N3CCN(C)CC3)c2c1C
5,6-dimethyl-4-(4-methylpiperazin-1-yl)-2-(phenylsulfanylmethyl)thieno[2,3-d]pyrimidine